User talk:Shifite004

Ref
Effect of Artesunate–Amodiaquine on Mortality Related to Ebola Virus Disease

Article Tools

Etienne Gignoux, M.P.H., Andrew S. Azman, Ph.D., Martin de Smet, M.D., Philippe Azuma, M.D., Moses Massaquoi, M.D., Dorian Job, M.D., Amanda Tiffany, M.P.H., Roberta Petrucci, M.D., Esther Sterk, M.D., M.I.H., Julien Potet, M.D., Motoi Suzuki, M.D., Andreas Kurth, Ph.D., Angela Cannas, Ph.D., Anne Bocquin, M.Sc., Thomas Strecker, Ph.D., Christopher Logue, Ph.D., Thomas Pottage, B.Sc., Constanze Yue, Ph.D., Jean-Clement Cabrol, M.D., Micaela Serafini, M.D., M.P.H., and Iza Ciglenecki, M.D.

Hide

January 7, 2016

N Engl J Med 2016; 374:23-32

What ref supports "As malaria treatment is recommended in Ebola virus disease patients, recently published data in New England Journal Of medicine shown that artemether plus amodiaquine lowers risk of death as compared to artemether plus lumefantrine in Ebola Virus disease Patients." Best Doc James  (talk · contribs · email) 09:41, 8 January 2016 (UTC)